← FDA Drug Approvals (Drugs@FDA)

ANDA211565

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK GENERICS · Approved 2020-04-27

Drug application

FDA Application #

ANDA211565

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

GLENMARK GENERICS

First approval

2020-04-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown